SALES (Tables)

3 Months Ended

Mar. 31, 2016

Sales Disclosure [Abstract]

SCHEDULE OF SALES BY PRODUCT TYPE

The Company’s sales by significant types of product for the three months ended March 31, 2016 and 2015 are as follows:

	For the three months ended
	March 31,		March 31,
	2016		2015
	USD		USD
Human Albumin		32,628,855		26,893,030
Immunoglobulin products:
Human Immunoglobulin for Intravenous Injection		34,157,762		32,865,791
Other Immunoglobulin products		8,900,316		4,334,122
Placenta Polypeptide		5,708,405		4,552,204
Others		4,192,373		1,709,184
Total		85,587,711		70,354,331